NCT04470934View on ClinicalTrials.gov

"SeQuent® SCB All Comers Post Market Clinical Follow-up (PMCF)"

Active, not recruitingOBSERVATIONAL
Enrollment

1,302

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2027

Conditions
Coronary Artery DiseaseMyocardial Ischaemia
Interventions
DEVICE

SeQuent® SCB drug-coated balloon catheter

"treatment of coronary artery disease with SeQuent® SCB of real world de-novo and restenotic lesions in native coronary arteries and coronary bypass grafts"

Trial Locations (1)

07747

Universitätsklinikum Jena, Jena

All Listed Sponsors
lead

B. Braun Melsungen AG

INDUSTRY